Julie Robinson, who oversees U.S.-side science on the International Space Station (ISS), names a one-time dark horse as her No. 1 research result to date from the orbiting laboratory. Medical researchers started running experiments in space more than a decade ago to see if working in microgravity would make it possible to encapsulate cancer drugs in tiny bubbles that could be targeted on specific tumors in the body. It turns out that it was, as the crew of ISS Expedition 5 discovered in ...


"Casis Boosts ISS Commercial Research Opportunities" is Premium Content. Subscribing will provide full access to this article as well as the opportunity to access:
-- Critical intelligence on the global aviation, aerospace & defense industries
-- Consolidated, comprehensive coverage of the programs and technologies shaping the industry
-- And much more…

Already registered? here.